Literature DB >> 28728872

Oropharyngeal lesions in pityriasis rosea.

Giulia Ciccarese1, Francesco Broccolo2, Alfredo Rebora3, Aurora Parodi3, Francesco Drago3.   

Abstract

BACKGROUND: Pityriasis rosea (PR) is an exanthematous disease associated with the endogenous systemic reactivation of human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV-7). Oropharyngeal lesions may be associated with the exanthema, but anecdotal evidence suggests that few dermatologists are aware of their occurrence.
OBJECTIVE: Classifying oropharyngeal lesions in PR, establishing their prevalence, and assessing their possible association with different PR forms.
METHODS: The records of all PR cases diagnosed in the Dermatology Clinic of Genoa University between 2003 and 2016 were retrospectively reviewed to examine sex and age of the patients, PR type, presence of enanthema, systemic symptoms, specific anti-HHV-6 and or HHV-7 serology, and HHV-6 and/or HHV-7 DNA loads.
RESULTS: The oropharyngeal mucosa was carefully examined in 527 patients with PR. Painless oropharyngeal lesions were observed in 149 patients with PR (28%) and classified as erythematomacular, macular and papular, erythematovesicular, and petechial lesions. The petechial and macular and papular patterns were those most frequently observed. There was no statistically significant difference in the levels of HHV-6 and HHV-7 viremia in the plasma of patients with enanthema and those without. LIMITATIONS: Because this was a retrospective study, biopsies on mucosal lesions were not performed.
CONCLUSION: Our findings showed that enanthemas are frequently associated with forms of PR different from the classic form.
Copyright © 2017 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  enanthemas; human herpesvirus 6/7; oropharyngeal lesions; pityriasis rosea

Mesh:

Year:  2017        PMID: 28728872     DOI: 10.1016/j.jaad.2017.06.033

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Pityriasis rosea in a patient with retrovirus infection: a reply.

Authors:  Giulia Ciccarese; Aurora Parodi; Francesca Drago; Astrid Herzum; Francesco Drago
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837

2.  [Comment on «Pityriasis rosea in a COVID-19 Pediatric Patient»].

Authors:  G Ciccarese; F Drago; A Parodi
Journal:  Actas Dermosifiliogr       Date:  2021-08-28

3.  Comment on "Pityriasis rosea in a COVID-19 Pediatric Patient".

Authors:  G Ciccarese; F Drago; A Parodi
Journal:  Actas Dermosifiliogr       Date:  2022-02-03

4.  The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.

Authors:  Giulia Ciccarese; Aurora Parodi; Francesco Drago
Journal:  Dermatol Ther       Date:  2022-06-13       Impact factor: 3.858

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.